FLAGSHIP HARBOR ADVISORS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1691766
BOSTON, MA
Position in REGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$574,844
-$96,682 QoQ
Shares Held
744
-14.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $1,374,943 across 4 Biotechnology names. REGN ranks #2 (41.8% of the industry book) .
All Filings in REGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $574,844 | 744 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $671,526 | 870 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $503,231 | 895 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $467,250 | 890 | Shares | Sole | 2025-08-04 | |
| 2024-09-30 | $256,502 | 244 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $264,859 | 252 | Shares | Sole | 2025-12-02 | |
| 2024-03-31 | $249,284 | 259 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $210,789 | 240 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $786,338 | 957 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $554,104 | 768 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $224,571 | 326 | Shares | Sole | 2022-10-13 | |
| 2020-09-30 | $124,271 | 222 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $173,998 | 279 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $82,521 | 169 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||